Related Experiment Video
Updated: Nov 7, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Repeated Mechanical Endovascular Thrombectomy for Recurrent Large Vessel Occlusion: A Multicenter Experience
Ghada A Mohamed1, Hassan Aboul Nour1, Raul G Nogueira2
1Department of Neurology, Henry Ford Hospital, Detroit, MI (G.A.M., H.A.N., L.S., D.M., A.B.C.).
Background And Purpose:
Mechanical thrombectomy (MT) is now the standard of care for large vessel occlusion (LVO) stroke. However, little is known about the frequency and outcomes of repeat MT (rMT) for patients with recurrent LVO.
Methods:
This is a retrospective multicenter cohort of patients who underwent rMT at 6 tertiary institutions in the United States between March 2016 and March 2020. Procedural, imaging, and outcome data were evaluated. Outcome at discharge was evaluated using the modified Rankin Scale.
Results:
Of 3059 patients treated with MT during the study period, 56 (1.8%) underwent at least 1 rMT. Fifty-four (96%) patients were analyzed; median age was 64 years. The median time interval between index MT and rMT was 2 days; 35 of 54 patients (65%) experienced recurrent LVO during the index hospitalization. The mechanism of stroke was cardioembolism in 30 patients (56%), intracranial atherosclerosis in 4 patients (7%), extracranial atherosclerosis in 2 patients (4%), and other causes in 18 patients (33%). A final TICI recanalization score of 2b or 3 was achieved in all 54 patients during index MT (100%) and in 51 of 54 patients (94%) during rMT. Thirty-two of 54 patients (59%) experienced recurrent LVO of a previously treated artery, mostly the pretreated left MCA (23 patients, 73%). Fifty of the 54 patients (93%) had a documented discharge modified Rankin Scale after rMT: 15 (30%) had minimal or no disability (modified Rankin Scale score ≤2), 25 (50%) had moderate to severe disability (modified Rankin Scale score 3-5), and 10 (20%) died.
Conclusions:
Almost 2% of patients treated with MT experience recurrent LVO, usually of a previously treated artery during the same hospitalization. Repeat MT seems to be safe and effective for attaining vessel recanalization, and good outcome can be expected in 30% of patients.
Insights
Nearly 2% of patients undergoing mechanical thrombectomy (MT) experience recurrent large vessel occlusion (LVO) stroke, often in the same artery. Repeat MT is safe and effective, with 30% of patients achieving good outcomes.
Area of Science:
- Neurology
- Interventional Neuroradiology
- Stroke Medicine
Background:
- Mechanical thrombectomy (MT) is the standard treatment for large vessel occlusion (LVO) stroke.
- Data on the frequency and outcomes of repeat MT (rMT) for recurrent LVO is limited.
Purpose of the Study:
- To investigate the incidence and outcomes of repeat mechanical thrombectomy (rMT) in patients experiencing recurrent large vessel occlusion (LVO) stroke.
Main Methods:
- Retrospective multicenter cohort study of 54 patients who underwent rMT across 6 US tertiary institutions (March 2016 - March 2020).
- Analysis included procedural data, imaging, and modified Rankin Scale (mRS) outcomes at discharge.
Main Results:
- 1.8% of 3059 MT patients underwent rMT; 65% of recurrent LVO occurred during the index hospitalization.
- Recurrent LVO often involved previously treated arteries (59%), primarily the left MCA.
- Successful recanalization (TICI 2b/3) was achieved in 94% of rMT procedures; 30% of patients had good outcomes (mRS ≤2), 50% had moderate-to-severe disability (mRS 3-5), and 20% died.
Conclusions:
- Recurrent LVO after MT occurs in approximately 2% of patients, frequently affecting previously treated vessels during the same hospitalization.
- Repeat MT is a safe and effective revascularization strategy.
- Approximately 30% of patients undergoing rMT can expect a favorable outcome.
More Related Videos
09:21Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023